|1.||Lin, Fang: 7 articles (07/2014 - 05/2004)|
|2.||Belletti, Barbara: 6 articles (01/2014 - 01/2005)|
|3.||Baldassarre, Gustavo: 6 articles (01/2014 - 01/2005)|
|4.||Wang, Xi: 5 articles (07/2014 - 11/2007)|
|5.||Wik, Elisabeth: 5 articles (01/2014 - 10/2010)|
|6.||Canzonieri, Vincenzo: 5 articles (01/2014 - 01/2005)|
|7.||Wang, Feng: 5 articles (01/2014 - 03/2008)|
|8.||Trovik, Jone: 5 articles (01/2014 - 10/2010)|
|9.||Colombatti, Alfonso: 5 articles (01/2014 - 01/2005)|
|10.||Zhang, Hui-Zhong: 5 articles (09/2010 - 05/2004)|
08/01/2014 - "A PubMed search using such terms as "stathmin", "microtubule dynamics", "epithelial-mesenchymal transition", "EMT", "malignant potential" and "cancer" was performed to identify relevant studies published in English. "
10/01/2013 - "Recently, stathmin 1 has been proposed to function as an oncogene based on some relevant studies in multiple types of human cancers. "
11/01/2011 - "Many studies suggest that high stathmin expression levels in cancer negatively influence the response to microtubule-targeting drugs. "
11/01/2008 - "In addition, through a combination of proteomics and immunological methods, this study demonstrates that stathmin 1alpha, a cytoskeletal protein implicated in tumor progression, undergoes a basic isoelectric point shift (p I) following uPAR suppression, suggesting that post-translational modification of stathmin occur secondary to uPAR suppression. "
01/01/2015 - "Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling."
|2.||Endometrial Neoplasms (Endometrial Cancer)
10/01/2010 - "Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer."
05/01/2013 - "High Stathmin expression has recently been associated with clinical progress in endometrial cancers. "
05/15/2011 - "Overexpression of the oncogen Stathmin has been linked to aggressive endometrial carcinoma and a potential for PI3Kinase inhibitors in this disease. "
01/01/2014 - "Stathmin is a prognostic marker in many cancers, including endometrial cancer. "
05/15/2011 - "Stathmin immunohistochemical staining identifies endometrial carcinomas with lymph node metastases and poor survival. "
|3.||Breast Neoplasms (Breast Cancer)
05/01/2007 - "Therefore, these data suggest a novel approach to improving the efficacy of certain antimicrotubule agents against breast cancer by regulating the function of stathmin."
05/01/2013 - "These studies provide the proof-of-principle that stathmin provides an attractive molecular target, which could serve as a primary focus of novel approaches to breast cancer."
05/01/2010 - "In a study of breast cancer cell lines(1) proposed that stathmin is required for survival of cells lacking p53, but this hypothesis was not tested directly. "
12/01/2015 - "Quantitative polymerase chain reaction and immunofluorescence by microscopic analysis of chimeras in vitro exhibited silencing of stathmin and survivin in the RB and breast cancer model. "
09/08/2015 - "Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients."
|4.||Stomach Neoplasms (Stomach Cancer)
10/01/2013 - "The aim of this study was to investigate the expression of stathmin 1 as well as its association with overall survival of gastric cancer patients. "
01/01/2015 - "Stathmin might be a potential molecular marker and target for the treatment of gastric cancer."
01/01/2015 - "Stathmin expression provides evidence for the treatment planning for gastric cancers. "
01/01/2015 - "Our results showed that the expression of stathmin was elevated in gastric cancer tissues, indicating a possible association between the stathmin expression and the disease occurrence. "
01/01/2015 - "Stathmin ASODN was transfected into gastric cancer SGC 7901 cell lines. "
06/15/2010 - "Colocalization of stathmin with TLR3 on astrocytes, microglia, and neurons in multiple sclerosis-affected human brain indicates that as an endogenous TLR3 agonist, stathmin may fulfill previously unsuspected regulatory roles during inflammation and repair in the adult CNS."
01/01/2015 - "Expression of stathmin phosphorylation-deficient mutant abolished ANP protective effects against PepG-induced inflammation and EC permeability. "
06/01/2015 - "Also, heat-induced overproduction of proinflammatory cytokines might be associated with downregulation of stathmin 1. Heat-induced hypothalamic ischemia, apoptosis, injury (or upregulation of L-lactate dehydrogenase), blood-brain-barrier disruption (or upregulation of glial fibrillary acidic protein), oxidative stress (or upregulation of cytosolic dehydrogenase-1), and activated inflammation (or downregulation of stathmin 1) were all significantly reversed by whole body cooling. "
|2.||Small Interfering RNA (siRNA)
|4.||Atrial Natriuretic Factor (ANF)
|6.||Messenger RNA (mRNA)
|7.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|8.||Proteins (Proteins, Gene)
|9.||Carrier Proteins (Binding Protein)
|10.||Complementary DNA (cDNA)
|1.||Drug Therapy (Chemotherapy)
|2.||Heterologous Transplantation (Xenotransplantation)